Fund Holdings — Merck & Co., Inc.

Total Portfolio Value:
$228.03M
Total Bought:
$0
Total Sold:
$0
Net Transaction:
$0
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Personalis, Inc.(PSNL)14,044,94314,044,9430$92.13M$91.57M40.16%-$561.8K
Moderna, Inc.(MRNA)2,308,1902,308,1900$63.68M$59.62M26.15%-$4.06M
Kymera Therapeutics, Inc.(KYMR)772,165772,1650$33.70M$43.70M19.17%+$10.01M
Alector Inc3,545,7193,545,7190$4.96M$10.50M4.60%+$5.53M
Entrada Therapeutics, Inc.(TRDA)1,739,7681,739,7680$11.69M$10.09M4.43%-$1.60M
Evaxion Biotech A/sADS1,214,1261,214,1260$2.97M$4.57M2.00%+$1.59M
Sutro Biopharma, Inc.(STRO)2,723,5092,723,5090$1.94M$2.37M1.04%+$420.8K
Viridian Therapeutics, Inc.(VRDN)93,41493,4140$1.31M$2.02M0.88%+$709.9K
Lava Therapeutics NvSHS1,149,3451,149,3450$1.52M$1.79M0.79%+$275.8K
Xilio Therapeutics, Inc.(XLO)1,483,7581,483,7580$1.01M$1.25M0.55%+$241.6K
Carisma Therapeutics Inc1,473,2401,473,2400$576.9K$403.7K0.18%-$173.3K
Neuphoria Therapeutics Inc10,02710,0270$71.2K$118.2K0.05%+$47.0K
TuHURA Biosciences, Inc.(HURA)13,95013,9500$31.1K$34.6K0.02%+$3.5K
Page 1 of 1